Primary cutaneous follicle centre lymphoma with secondary systemic evolution

Author:

Li Andy123,Lehmann‐Che Jacqueline134,Champ Jérôme4,Rivet Jacqueline5,Vignon‐Pennamen Marie‐Dominique5,Mourah Samia136,Cayuela Jean‐Michel7,Lepelletier Clémence2,Louveau Baptiste136,Dumont Maëlle2,Alhage Jana2,Ram‐Wolff Caroline2,Bouaziz Jean‐David123ORCID,Bagot Martine123ORCID,De Masson Adèle123ORCID,Battistella Maxime135

Affiliation:

1. INSERM UMR‐S U976, HIPI Institut de Recherche Saint‐Louis Paris France

2. Dermatology Department APHP, Hôpital Saint‐Louis Paris France

3. Université Paris Cité Paris France

4. Tumor Genomics Department, Molecular Oncology Unit, APHP Hôpital Saint‐Louis Paris France

5. Pathology Department, APHP Hôpital Saint‐Louis Paris France

6. Tumor Genomics Department, Pharmacogenomics Unit, APHP Hôpital Saint‐Louis Paris France

7. Hematology Laboratory APHP, Hôpital Saint‐Louis Paris France

Abstract

AbstractPrimary cutaneous follicle centre lymphomas (PCFCLs) are cutaneous proliferation of centrocytes and centroblasts, with a generally indolent evolution. Secondary systemic spread of disease is a rare event, which significantly impairs prognosis. Recently published study by Zhou and al. proposed criteria aiming to predict such evolution at initial stage: (i) rearrangement of Bcl2, (ii) Ki67% index <30% and (iii) 2 mutations among the CREBBP, KMT2D, EZH2 and EP300.1 genes. We herein report two cases of PCFCLs with systemic evolution. Both patients had been initially diagnosed with localised skin disease, and developed, several years after, a secondary systemic involvement. Skin biopsies at the initial stage and systemic spread were analysed by histology, immunohistochemistry, fluorescence in situ hybridisation, and by DNA sequencing of a panel of 54 genes frequently mutated in lymphomas. Both patients showed no rearrangement of Bcl2, >30% Ki67% indexes and no mutations among the four proposed genes. These findings run contrary to these previously proposed criteria, highlighting the molecular heterogeneity of this rare disease.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3